A dual institution real-world study of avelumab for advanced Merkel cell carcinoma

被引：0
|
作者：
Miller, David Michael
Wright, Kayla
Silk, Ann W.
Thakuria, Manisha
Shalhout, Sophia
机构：
[1] Massachusetts Gen Hosp, Boston, MA USA
[2] Massachusetts Eye & Ear, Boston, MA USA
[3] Dana Farber Canc Inst, Boston, MA USA
[4] Harvard Med Sch, Boston, MA USA
[5] Brigham & Womens Hosp, Boston, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21514
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Cost Effectiveness of Avelumab for Metastatic Merkel Cell Carcinoma
    Ash Bullement
    Paul Nathan
    Anna Willis
    Amerah Amin
    Cameron Lilley
    Ceilidh Stapelkamp
    Anthony Hatswell
    Chris Pescott
    Murtuza Bharmal
    PharmacoEconomics - Open, 2019, 3 : 377 - 390
  • [32] Hyperprogression of Merkel cell carcinoma after avelumab treatment
    Pirker, R.
    Fink, A.
    Stella, A.
    Stifter, L.
    Posch, C.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023, 37 (05) : E675 - E677
  • [33] Avelumab and other recent advances in Merkel cell carcinoma
    Bommareddy, Praveen K.
    Kaufman, Howard L.
    FUTURE ONCOLOGY, 2017, 13 (30) : 2771 - 2783
  • [34] Avelumab effective against Merkel-cell carcinoma
    Peter Sidaway
    Nature Reviews Clinical Oncology, 2016, 13 (11) : 652 - 652
  • [35] Real-world treatment outcomes in patients with metastatic Merkel cell carcinoma treated with chemotherapy in the USA
    Cowey, C. Lance
    Mahnke, Lisa
    Espirito, Janet
    Helwig, Christoph
    Oksen, Dina
    Bharmal, Murtuza
    FUTURE ONCOLOGY, 2017, 13 (19) : 1699 - 1710
  • [36] AUSTRALI-AVE: Design of a retrospective noninterventional study evaluating real-world patient characteristics and treatment patterns with avelumab in locally advanced or metastatic urothelial cancer (la/mUC) and metastatic Merkel cell carcinoma (mMCC) in Australia
    Ben Tran
    Moujaber, Tania
    Oliveira, Niara
    Shackleton, Mark
    Pook, David
    Franchini, Fanny
    Kouhkamari, Mahsa H.
    Schoeninger, Brittany
    Miles, Alison G.
    Wu, Beilei
    Bennett, Greer
    Varrasso, Annalisa
    Liu, Xiao
    Hoffman, Jason
    Kearney, Mairead
    Xu, Wen
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2024, 20 : 269 - 270
  • [37] Real-World Treatment Patterns and Clinical Outcomes in Patients With Locally Advanced or Metastatic Urothelial Carcinoma by Eligibility for Maintenance Avelumab
    Morgans, Alicia K.
    Sonpavde, Guru P.
    Shih, Vanessa
    Wright, Phoebe
    Hepp, Zsolt
    Willmon, Candice L.
    Chang, Nancy N.
    Mucha, Lisa
    Naga, Sai Sriteja Boppudi
    Powles, Thomas
    CLINICAL GENITOURINARY CANCER, 2024, 23 (01)
  • [38] Real-World Evidence of Tumor and Patient Characteristics and Survival with Avelumab Maintenance after Chemotherapy for Advanced and Metastatic Urothelial Carcinoma
    Banek, Severine
    Wenzel, Mike
    Lauer, Benedikt
    Le, Quynh Chi
    Hoeh, Benedikt
    Koll, Florestan
    Cano Garcia, Cristina
    Humke, Clara
    Koellermann, Jens
    Chun, Felix K. H.
    Kosiba, Marina
    Kluth, Luis A.
    UROLOGIA INTERNATIONALIS, 2024, 108 (04) : 285 - 291
  • [39] UK real-world observational study of avelumab plus axitinib (A plus Ax) in advanced renal cell carcinoma (aRCC): 24-month interim results.
    Nathan, Paul D.
    Charnley, Natalie
    Frazer, Ricky
    McGrane, John
    Muazzam, Iqtedar A.
    Rudman, Sarah
    Sharma, Anand
    Stevenson, Robert
    Hickey, Joseph David
    Tahim, Arpan
    Ritchie, Aimi Rose
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [40] Avelumab to treat Merkel cell carcinoma: real-life experience in a dedicated oncology center
    Rios-Vinuela, E.
    Garcia-Vazquez, M.
    Juan, M. J.
    Nagore, E.
    Requena, C.
    Sanmartin, O.
    Llombart, B.
    ACTAS DERMO-SIFILIOGRAFICAS, 2025, 116 (01): : 81 - 86
12345